RENAISSANCE TECHNOLOGIES LLC

Position in RNTX — Rein Therapeutics, Inc.

CIK 1037389 NEW YORK, NY

Position in RNTX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$19,760

-$12,090 QoQ

Shares Held

19,000

-22.4% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#46

of 59 holders

Holding Since

Dec 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,952,593,796 across 312 Biotechnology names. RNTX ranks #297 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$19,760	19,000	-22.4%	Shares	Sole	2026-08-13
2026-03-31	$31,850	24,500	+7.9%	Shares	Sole	2026-05-14
2025-12-31	$26,332	22,700	+24.1%	Shares	Sole	2026-02-12
2025-09-30	$20,951	18,298	+39.0%	Shares	Sole	2025-11-13
2024-09-30	$46,600	13,164	-47.1%	Shares	Sole	2024-11-13
2024-06-30	$68,873	24,864	-44.8%	Shares	Sole	2024-08-09
2024-03-31	$298,774	45,064	+60.8%	Shares	Sole	2024-05-13
2023-12-31	$85,429	28,019	+47.7%	Shares	Sole	2024-02-13
2023-09-30	$28,825	18,964	+19.5%	Shares	Sole	2023-11-14
2023-06-30	$28,396	15,864	+25.3%	Shares	Sole	2023-08-11
2023-03-31	$15,703	12,664	+19.9%	Shares	Sole	2023-05-12
2022-12-31	$25,036	10,564	—	Shares	Sole	2023-02-13
No filing history on record for this holder in this stock.